ProKidney
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProKidney and other ETFs, options, and stocks.About PROK
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD.
PROK Key Statistics
Stock Snapshot
As of today, ProKidney(PROK) shares are valued at $1.66. The company's market cap stands at 501.29M, with a P/E ratio of -3.32.
As of 2026-05-15, ProKidney(PROK) stock has fluctuated between $1.59 and $1.73. The current price stands at $1.66, placing the stock +4.4% above today's low and -4.0% off the high.
ProKidney(PROK) shares are trading with a volume of 635.76K, against a daily average of 757.96K.
During the past year, ProKidney(PROK) stock moved between $0.54 at its lowest and $7.13 at its peak.
During the past year, ProKidney(PROK) stock moved between $0.54 at its lowest and $7.13 at its peak.
PROK News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Reports Q1 revenue $226,000, consensus $100,250.”As we progress through 2026, we continue to build on the momentum established last year through positive Phase...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.